GB201703529D0 - Vaccine composition - Google Patents

Vaccine composition

Info

Publication number
GB201703529D0
GB201703529D0 GBGB1703529.6A GB201703529A GB201703529D0 GB 201703529 D0 GB201703529 D0 GB 201703529D0 GB 201703529 A GB201703529 A GB 201703529A GB 201703529 D0 GB201703529 D0 GB 201703529D0
Authority
GB
United Kingdom
Prior art keywords
vaccine composition
vaccine
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1703529.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cambridge Enterprise Ltd
Original Assignee
Cambridge Enterprise Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge Enterprise Ltd filed Critical Cambridge Enterprise Ltd
Priority to GBGB1703529.6A priority Critical patent/GB201703529D0/en
Publication of GB201703529D0 publication Critical patent/GB201703529D0/en
Priority to PCT/EP2018/055377 priority patent/WO2018162428A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GBGB1703529.6A 2017-03-06 2017-03-06 Vaccine composition Ceased GB201703529D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1703529.6A GB201703529D0 (en) 2017-03-06 2017-03-06 Vaccine composition
PCT/EP2018/055377 WO2018162428A1 (en) 2017-03-06 2018-03-05 Pentavalent streptococcus suis vaccine composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1703529.6A GB201703529D0 (en) 2017-03-06 2017-03-06 Vaccine composition

Publications (1)

Publication Number Publication Date
GB201703529D0 true GB201703529D0 (en) 2017-04-19

Family

ID=58543974

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1703529.6A Ceased GB201703529D0 (en) 2017-03-06 2017-03-06 Vaccine composition

Country Status (2)

Country Link
GB (1) GB201703529D0 (en)
WO (1) WO2018162428A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113332421B (en) * 2021-07-02 2022-07-19 江苏省农业科学院 Vaccine for swine streptococcosis
WO2023203238A1 (en) * 2022-04-22 2023-10-26 Intervacc Ab Streptococcus suis vaccine composition comprising immunogenic fusion polypeptides

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5078996A (en) 1985-08-16 1992-01-07 Immunex Corporation Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
US5084269A (en) 1986-11-06 1992-01-28 Kullenberg Fred W Adjuvant for dose treatment with antigens
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
US4912094B1 (en) 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
CA2017507C (en) 1989-05-25 1996-11-12 Gary Van Nest Adjuvant formulation comprising a submicron oil droplet emulsion
IL101715A (en) 1991-05-02 2005-06-19 Amgen Inc Recombinant dna-derived cholera toxin subunit analogs
WO1993013302A1 (en) 1991-12-23 1993-07-08 Michael Zoche Engine with oil separator
DE69419966T2 (en) * 1993-05-17 2000-01-20 Akzo Nobel Nv Vaccine against Streptococcus suis infection
US5571515A (en) 1994-04-18 1996-11-05 The Wistar Institute Of Anatomy & Biology Compositions and methods for use of IL-12 as an adjuvant
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
KR100780158B1 (en) 1996-10-23 2007-11-27 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 Immunotherapy and Improved Vaccines
US6113918A (en) 1997-05-08 2000-09-05 Ribi Immunochem Research, Inc. Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
AU759603B2 (en) 1998-02-27 2003-04-17 Trustees Of The University Of Pennsylvania, The Vaccines, immunotherapeutics and methods for using the same
BR9914160A (en) 1998-09-30 2001-06-26 American Cyanamid Co Antigenic composition, method for increasing the capacity of an antigenic composition that contains an antigen selected from a pathogenic bacterium, virus, fungus or parasite, haemophilus influenzae, helicobacter pylori, respiratory syncytial virus, rotavirus, and simple virus of the herpes to evoke the immune response of a vertebrate host, plasmid, host cell, method to produce an immunogenic mutant cholera holotoxin, and use of an effective auxiliary amount of a mutant cholera holotoxin
AU769539B2 (en) 1999-01-29 2004-01-29 Zoetis Services Llc Adjuvants for use in vaccines
CA2449663A1 (en) 2001-06-07 2002-12-12 Wyeth Holdings Corporation Mutant forms of cholera holotoxin as an adjuvant
EP1404279A4 (en) 2001-06-07 2007-08-08 Wyeth Corp Mutant forms of cholera holotoxin as an adjuvant
CA2496750C (en) 2002-08-26 2014-10-21 Pfizer Products Inc. Vaccine for respiratory and reproductive system infections in cattle
EP2481423A1 (en) 2006-01-26 2012-08-01 Pfizer Products Inc. Novel glycolipid adjuvant compositions
PT2078080E (en) 2006-09-27 2015-09-18 Coley Pharm Gmbh Cpg oligonucleotide analogs containing hydrophobic t analogs with enhanced immunostimulatory activity
CA2960734C (en) 2008-06-27 2021-08-24 Zoetis Services Llc Adjuvants containing saponins, sterols and quaternary amines
EP2277534A1 (en) * 2009-07-20 2011-01-26 Universidad De Córdoba Immunogenic and therapeutic compositions for streptococcus suis
US10117921B2 (en) 2013-09-19 2018-11-06 Zoetis Services Llc Oil-based adjuvants
US11155585B2 (en) * 2015-07-09 2021-10-26 Intervacc Ab Vaccine against S. suis infection

Also Published As

Publication number Publication date
WO2018162428A1 (en) 2018-09-13

Similar Documents

Publication Publication Date Title
ZA201801035B (en) Vaccine compositions
SG11202010821TA (en) Vaccine composition
GB201610599D0 (en) Immunogenic Composition
GB201703455D0 (en) Composition
GB201711635D0 (en) Immunogenic composition
GB201707120D0 (en) Composition
GB201719139D0 (en) Composition
GB201711637D0 (en) Immunogenic composition
GB201700504D0 (en) Composition
GB201713636D0 (en) Composition
GB201712151D0 (en) Composition
GB201614485D0 (en) Immunogenic composition
GB2562241B (en) Vaccine compositions
IL271603A (en) Immunogenic compositions
GB201604755D0 (en) Immunogenic compositions
EP3675653C0 (en) Antimycotoxin composition
GB201703529D0 (en) Vaccine composition
GB201702833D0 (en) Composition
GB201718251D0 (en) Vaccine Compositions
EP3677276A4 (en) Vaccine composition
GB201721674D0 (en) Composition
GB201718871D0 (en) Composition
GB201717224D0 (en) Composition
GB201715135D0 (en) Composition
GB201711446D0 (en) Composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)